Drug Shortage Report for FASTURTEC
| Report ID | 16581 |
| Drug Identification Number | 02248416 |
| Brand name | FASTURTEC |
| Common or Proper name | Fasturtec 1.5mg vial powder plus 1.0mL solvent |
| Company Name | SANOFI-AVENTIS CANADA INC |
| Market Status | MARKETED |
| Active Ingredient(s) | RASBURICASE |
| Strength(s) | 1.5MG |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 3 vials |
| ATC code | V03AF |
| ATC description | ALL OTHER THERAPEUTIC PRODUCTS |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | |
| Actual start date | 2017-07-17 |
| Estimated end date | 2017-09-04 |
| Actual end date | 2017-08-16 |
| Shortage status | Resolved |
| Updated date | 2017-08-17 |
| Company comments | RESOLVED/RELEASED 2017-08-16 |
| Health Canada comments | |
| Tier 3 Status | No |
| Company contact information | email: CAINTERNET@sanofi.com Telephone: 1-800-265-7927 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v5 | 2017-08-17 | English | Compare |
| v4 | 2017-08-16 | French | Compare |
| v3 | 2017-08-16 | English | Compare |
| v2 | 2017-07-21 | French | Compare |
| v1 | 2017-07-21 | English | Compare |
Showing 1 to 5 of 5